// App-Quantinova.ai

: Long-Term Efficacy Analysis of Allogeneic Hematopoietic Stem Cell Transplantation in the Treatment of Acute Myeloid Leukemia Using Melphalan Instead of Cyclophosphamide As a Myeloablative Conditioning Regimen

Researchers

Presenter

  • Ying Zhang

Principal Investigators

  • Aiming Pang

  • Donglin Yang

  • Yong Huang

  • Jialin Wei

  • Yi He

  • Qiaoling Ma

  • Sizhou Feng

  • Mingzhe Han

  • Erlie Jiang

Medical Centers

  • State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, CAMS & PUMC, Tianjin, China

Locations

  • China

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

  • Oncology (ONC)

Disease

  • Graft-versus-host disease

  • Acute myelocytic leukemia

Biomarkers

  • N/A

Drug/Treatment

  • Mycophenolate mofetil

  • CKD-4101

  • Cyclophosphamide

  • Cyclophosphamide Injection

  • Cyclosporine A

  • Mycophenolic acid

  • Cyclosporine eent

  • Methotrexate

  • fludarabine tablet

  • Cytarabine liposomal

  • Tacrolimus

  • Melphalan

  • ara-c

Outcome

  • N/A

Study Design

  • Efficacy

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved